Altmetric
Browse
21053 Case Study - Altmetric Neurocrine Biosciences WEB2.pdf (187.63 kB)

How Neurocrine Biosciences used altmetrics to measure success

Download (187.63 kB)
online resource
posted on 2021-12-09, 14:45 authored by Altmetric EngineeringAltmetric Engineering
Neurocrine Biosciences is a neuroscience-focused, biopharmaceutical company dedicated to discovering, developing and delivering life-changing treatments for people with serious, challenging and under-addressed neurological, endocrine and psychiatric disorders.

For nearly three decades, Neurocrine Biosciences has specialized in FDA-approved treatments for tardive dyskinesia, Parkinson’s disease, endometriosis, uterine fibroids and clinical programs in multiple therapeutic areas.

Chirag Shah, Head of Publications Strategy and
Office of Grants/Education at Neurocrine Biosciences, spoke to us about how altmetrics were particularly helpful in the therapeutic area of tardive dyskinesia (TD)

History

Usage metrics

    Altmetric

    Categories

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC